The classic ILD dilemma
To immunosuppress or not to immunosuppress? That is the question!
DAY 1
Chaired by: Dr Sophie Fletcher (Southampton), Dr Paul Minnis (Antrim)
11.30am - Morphologic patterns of interstitial and alveolar fillings disorders - clinical cases
Dr Melanie Greaves (Manchester)
12.00pm - CTD ILD – what are the drug options
Ms Marium Naqvi (London)
12.30pm - Hypersensitivity pneumonitis, steroids, steroid sparing agents or nothing at all?
Professor Michael Gibbons (Exeter)
11:30 AM
90 MINUTE SESSION
Learning outcomes
- Provide an update on recent trial evidence for the use of steroids or methotrexate for first line treatment of sarcoid.
- Comprehensive review of drug options for those with CTD ILD, indications, cautions and evidence base.
- Update on current understanding of the management of HP, the role of immunosuppression, BAL and future research questions.
Curriculum mapping
Respiratory Specialty CiPs
- Managing all aspects of advanced respiratory disease including diagnostic pathways and working with the MDT.
- Demonstrates diagnostic acumen.
- Ability to perform relevant diagnostic tests and procedures.
- Knowledge of guidelines and ability to apply them to practice.
- Communication with GP and specialist colleagues.
- Ability to construct decision algorithms (e.g. planning in advance the different possible courses of action resulting from investigation results) .
- Tertiary subspecialties interface: managing patients across the secondary and tertiary interface.
- Demonstrates ability to consider the diagnosis of interstitial lung diseases and other orphan lung diseases.
- Knowledge of diagnostic criteria for rare lung diseases.
- Presentation of cases at specialist MDT.
- Demonstrates good communication skills when dealing with tertiary centres.
- Demonstrates knowledge of these disorders and ability to manage patients locally in a joint care model when appropriate.